California is taking decisive action to regulate private equity and hedge fund involvement in healthcare. With Gov. Newsom signing SB 351 and AB 1415, the state is codifying long-standing prohibitions on the corporate practice of medicine and dentistry while significantly expanding the Office of Health Care Affordability’s authority to review healthcare transactions – particularly those involving private equity groups, hedge funds, and management services organizations.

Join us for an in-depth discussion that breaks down:

• The key provisions of SB 351 and AB 1415, and the factors that prompted California’s legislative push.
• The immediate implications for private equity sponsors and hedge fund sponsors, and their California portfolio companies.
• The compliance challenges and structuring considerations as we approach the 2026 effective date.
• How these changes could ripple across the US and cross-border investments.

Whether you advise funds, investors, or targets with California exposure, this session will provide the practical insights and strategies needed to stay ahead of the new regulatory curve.

Read our client alerts on these developments

AB 1415 expands OHCA’s authority over PE, hedge fund investments

Newsom signs SB 351, codifying existing California CPOM guidance